Patents by Inventor Takashi Nara

Takashi Nara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4808223
    Abstract: This invention relates to a silver/metal oxide material for electrical contacts containing no Cd which essentially consists of Ag and 5 to 30% by weight of at least one of oxides of Sb, Sn, Zn, In, Cu, Mn, Bi and Pb, and further, if necessary, 0.05 to 2% by weight of at least one of oxides of Mg, Al, Fe, Ni, Co, Si, Ga, Ge, Te, Ca and Li, the total amount of said metal oxides being 5 to 32% by weight, wherein fine particles of said metal oxides are substantially uniformly distributed in a matrix whose main component is Ag in a sintered state, and wherein there are no grain boundaries formed by agglomerations or agglomerated layers of said metal oxides.
    Type: Grant
    Filed: July 7, 1987
    Date of Patent: February 28, 1989
    Assignees: Fuji Electric Co., Ltd., Tokuriki Honten Co., Ltd.
    Inventors: Ryoji Ozaki, Hisaji Shinohara, Hironobu Yamamoto, Takashi Nara, Hajime Yoshida
  • Patent number: 4761779
    Abstract: In this invention, a call control information of a subscriber's line is compiled into a packet form, is transferred via a network of a digital switch board to a signal control device, and digital data is also transferred via the network to a handler. Accordingly, a signal from a digital subscriber is efficiently processed, and an analog subscriber is also accommodated so that a call control in the same way as for the digital subscriber is made possible for the analog subscriber.
    Type: Grant
    Filed: November 20, 1986
    Date of Patent: August 2, 1988
    Assignee: Fujitsu Limited
    Inventors: Takashi Nara, Hiroaki Takeichi, Yoshio Morita, Takashi Hatano, Yutaka Kawato
  • Patent number: 4754273
    Abstract: A digital subscriber line formed by terminal equipment, a network control device including a plurality of the terminal equipment, and an exchange terminal. In a waiting state of the digital subscriber line, the network control derive is placed in a state which can only receive a signal. A sending portion of the network control device is driven when, at a call from the terminal equipment, the terminal control device receives a line activation signal from the exchange equipment and when, at an incoming state from the state from the exchange terminal, the terminal control device receives a line activation from the exchange equipment. The synchronization pattern signal is sent from the sending portion to the exchange terminal so that the synchronization of the exchange terminal is established.
    Type: Grant
    Filed: August 14, 1987
    Date of Patent: June 28, 1988
    Assignee: Fujitsu Limited
    Inventors: Sumie Okada, Takashi Nara, Takashi Hatano, Yutaka Kawato, Ryoji Shimozono, Kenji Tsutsumi, Yasunori Ogawa, Yasuo Tanaka
  • Patent number: 4698801
    Abstract: A digital exchange system including exchange terminals, a digital network, and a bit rate conversion unit located therebetween. The bit rate conversion unit operates to match low bit-rate channel signals with high bit-rate channel signals acceptable by the digital network, by multiplexing a plurality of the outgoing low bit-rate channel signals. The bit-rate conversion unit operates, on the other hand, to demultiplex the incoming multiplexed low bit-rate channel signals.
    Type: Grant
    Filed: December 27, 1984
    Date of Patent: October 6, 1987
    Assignee: Fujitsu Limited
    Inventors: Takashi Hatano, Takashi Nara, Yutaka Kawato, Sumie Okada
  • Patent number: 4661946
    Abstract: A digital switch module for a time division digital switching system includes an encoding law conversion memory and a control memory. The encoding law conversion memory has previously stored therein conversion data for converting between different types of encoding laws. For example, the A-law and .mu.-law encoding laws set forth in CCITT Recommendation G.711 can be converted by a digital switch module according to the present invention. The encoding law conversion memory includes a read only memory having regions for conversion between A-law and .mu.-law encoded data and for nonconversion of both A-law and .mu.-law encoded data. The control memory designates which of the regions in the encoding law conversion memory is to be used during each time slot, thus dynamically controlling whether data passing through the digital switch module is converted or not. The type of conversion or nonconversion designated by the control memory can be determined by the type of data, e.g.
    Type: Grant
    Filed: May 29, 1985
    Date of Patent: April 28, 1987
    Assignee: Fujitsu Limited
    Inventors: Atsuhisa Takahashi, Takashi Nara, Masami Murayama, Hiroaki Takeichi
  • Patent number: 4659384
    Abstract: A gallium alloy for dental restorations which is hardenable at mouth temperature or around 37.degree. C. or more after triturating multicomponent liquid gallium alloy with alloy powder, is disclosed. The mixture has a heterogeneous structure after hardening, and contains as the overall composition, 9-47% gallium, 1-35% indium, 0.2-38% tin and 1-68% silver as indispensable components and one or more elements selected from 0.4-35% palladium, 0.5-25% copper and 0.4-12% zinc as arbitrary components. The multicomponent liquid gallium alloy contains 45-85% gallium, 5-40% indium and 1-30% tin as fundamental components and small amounts one or more elements selected from silver, palladium, gold, platinium, copper, zinc and germanium as arbitrary components. The alloy powder contains 1-85% silver and two or more elements selected from 1-40% tin, 1-40% palladium, 1-30% copper, 1-15% zinc and 1-25% indium.
    Type: Grant
    Filed: June 20, 1985
    Date of Patent: April 21, 1987
    Assignee: Tokuriki Honten Company, Limited
    Inventors: Yasuhito Daigo, Takashi Horibe, Kengo Inage, Shigeyasu Naruse, Takashi Nara, Yoshizo Okamoto, Hironobu Yamamoto
  • Patent number: 4316957
    Abstract: The antibacterial compounds 7-deazaadenosine and 7-deazinosine are produced by fermentation of a new microorganism of the genus Micromonospora. At least one of the active substances is isolated from the culture medium.
    Type: Grant
    Filed: April 4, 1978
    Date of Patent: February 23, 1982
    Assignee: Abbott Laboratories
    Inventors: Takashi Nara, Ryo Okachi, Isao Kawamoto, Tomoyasu Sato, Tetsuo Oka
  • Patent number: 4310661
    Abstract: New antibacterial compounds, XK-62-3 and XK-62-4, are produced by fermentation of microorganisms belonging to the genus Micromonospora. The compounds are accumulated in the culture liquor and are isolated therefrom.
    Type: Grant
    Filed: December 23, 1980
    Date of Patent: January 12, 1982
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Takao Iida, Kunikatsu Shirahata, Shinzo Ishii, Ryo Okachi, Takashi Nara
  • Patent number: 4298690
    Abstract: New antibacterial compounds, XK-62-3 and XK-62-4, are produced by fermentation of microorganisms belonging to the genus Micromonospora. The compounds are accumulated in the culture liquor and are isolated therefrom.
    Type: Grant
    Filed: May 16, 1978
    Date of Patent: November 3, 1981
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Takao Iida, Kunikatsu Shirahata, Shinzo Ishii, Ryo Okachi, Takashi Nara
  • Patent number: 4218562
    Abstract: Derivatives of the antibiotic XK-62-2 are prepared by chemically modifying the antibiotic XK-62-2. An example of one such derivative is 1-N-[L-(-)-.alpha.-hydroxy-.gamma.-aminobutyryl]XK-62-2.
    Type: Grant
    Filed: March 15, 1978
    Date of Patent: August 19, 1980
    Assignee: Abbott Laboratories
    Inventors: Kunikatsu Shirahata, Shinji Tomioka, Takashi Nara, Hideo Matsushima, Isao Matsubara
  • Patent number: 4216308
    Abstract: New antibiotic compounds, Fortimicin factors D and KE are produced by fermentation of microorganisms belonging to the genus Micromonospora. The antibiotic compounds are accumulated in the culture liquor and are isolated therefrom. A semisynthetic method of producing Fortimicin KE utilizing Fortimicin D is also disclosed.
    Type: Grant
    Filed: December 29, 1978
    Date of Patent: August 5, 1980
    Assignee: Abbott Laboratories
    Inventors: Takao Iida, Kunikatsu Shirahata, Isao Matsubara, Masahiro Sugimoto, Shinzo Ishii, Ryo Okachi, Takashi Nara
  • Patent number: 4209612
    Abstract: New antibiotic compounds, Fortimicin factors KF and KG are produced by fermentation of microorganisms belonging to the genus Micromonospora. The antibiotic compounds are accumulated in the culture liquor and are isolated therefrom.
    Type: Grant
    Filed: November 6, 1978
    Date of Patent: June 24, 1980
    Assignee: Abbott Laboratories
    Inventors: Keiichi Takahashi, Takao Iida, Kunikatsu Shirahata, Masahiro Sugimoto, Shinzo Ishii, Ryo Okachi, Takashi Nara
  • Patent number: 4162305
    Abstract: A novel antibacterial compound, XK-99, is produced by fermentation of an organism belonging to the genus Micromonospora. The compound is isolated from the microbial cells and culture liquor.
    Type: Grant
    Filed: March 29, 1978
    Date of Patent: July 24, 1979
    Assignee: Abbott Laboratories
    Inventors: Takashi Nara, Ryo Okachi, Isao Kawamoto, Tomoyasu Sato, Tetsuo Oka
  • Patent number: 4145253
    Abstract: New antibiotic compounds, Fortimicin factors D and KE are produced by fermentation of microorganisms belonging to the genus Micromonospora. The antibiotic compounds are accumulated in the culture liquor and are isolated therefrom. A semisynthetic method of producing Fortimicin KE utilizing Fortimicin D is also disclosed.
    Type: Grant
    Filed: October 27, 1977
    Date of Patent: March 20, 1979
    Assignee: Abbott Laboratories
    Inventors: Takao Iida, Kunikatsu Shirahata, Isao Maisubara, Masahiro Sugimoto, Shinzo Ishii, Ryo Okachi, Takashi Nara
  • Patent number: 4109077
    Abstract: Derivatives of the antibiotic XK-62-2 are prepared by chemically modifying the antibiotic XK-62-2. An example of one such derivative is 1-N-[L-(-)-.alpha.-hydroxy-.gamma.-aminobutyryl] XK-62-2.
    Type: Grant
    Filed: June 3, 1976
    Date of Patent: August 22, 1978
    Assignee: Abbott Laboratories
    Inventors: Kunikatsu Shirahata, Shinji Tomioka, Takashi Nara, Hideo Matsushima, Isao Matsubara
  • Patent number: 4097428
    Abstract: A new antibiotic, Fortimicin C, is produced by fermentation of a microorganism belonging to the genus Micromonospora. The antibiotic is accumulated in the culture medium and is isolated therefrom.
    Type: Grant
    Filed: May 26, 1977
    Date of Patent: June 27, 1978
    Assignee: Abbott Laboratories
    Inventors: Takashi Nara, Ryo Okachi, Mitsuyoshi Yamamoto, Yasuki Mori, Moriyuki Sato, Masahiro Sugimoto, Yoshiaki Shimizu
  • Patent number: 4055715
    Abstract: 1-N-[L-(-)-.alpha.-hydroxy-.gamma.-aminobutyryl]XK-62-2 is produced by chemically modifying the antibiotic XK-62-2.
    Type: Grant
    Filed: January 22, 1975
    Date of Patent: October 25, 1977
    Assignee: Abbott Laboratories
    Inventors: Shinji Tomioka, Yasuki Mori, Takashi Nara, Kunikatsu Shirahata
  • Patent number: 4048015
    Abstract: A new antibiotic, Fortimicin C, is produced by fermentation of a microorganism belonging to the genus Micromonospora. The antibiotic is accumulated in the culture medium and is isolated therefrom.
    Type: Grant
    Filed: July 26, 1976
    Date of Patent: September 13, 1977
    Assignee: Abbott Laboratories
    Inventors: Takashi Nara, Ryo Okachi, Mitsuyoshi Yamamoto, Yasuki Mori, Moriyuki Sato, Masahiro Sugimoto, Yoshiaki Shimizu
  • Patent number: 4045610
    Abstract: A novel series of antibiotics designated the XK-88 series are produced by culturing a microorganism belonging to the genus Streptomyces in a nutrient medium and thereafter recovering the antibiotics from the culture liquor.
    Type: Grant
    Filed: October 17, 1975
    Date of Patent: August 30, 1977
    Assignee: Abbott Laboratories
    Inventors: Takashi Nara, Seigo Takasawa, Ryo Okachi, Isao Kawamoto, Mitsuyoshi Yamamoto, Seiji Sato, Tomoyasu Sato, Atsuko Morikawa
  • Patent number: 4045298
    Abstract: The antibiotic XK-62-2 is produced by fermentation of microorganisms belonging to the genus Micromonospora. The antibiotic is accumulated in the culture liquor and is isolated therefrom.
    Type: Grant
    Filed: June 15, 1976
    Date of Patent: August 30, 1977
    Assignee: Abbott Laboratories
    Inventors: Takashi Nara, Seigo Takasawa, Ryo Okachi, Isao Kawamoto, Mitsuyoshi Yamamoto, Seiji Sato, Tomoyasu Sato, Atsuko Morikawa